AI Terminal
Vimian Group AB
Regulatory Filings • Dec 30, 2025
8618_rns_2025-12-30_597bd054-43b9-4c52-a4c1-64b388edbf1a.pdf
Regulatory Filings
Open in ViewerOpens in native device viewer
Press Release 30 December 2025 17:30:00 CET
Change in the number of shares and votes in Vimian
The number of shares and votes in Vimian Group AB (publ) ("Vimian") increased during December as a result of the share issue of D shares, E1 2025 shares, E2 2025 shares, and E3 2025 shares within the framework of Vimian's incentive program LTIP 2025/2028 as well as conversion of C shares into ordinary shares. The number of shares increased by a total of 596,437 shares, of which 418,269 were D shares, 59,390 were E1 2025 shares, 59,389 were E2 2025 shares, and 59,389 were E3 2025 shares. Furthermore 218 C shares were converted into 218 ordinary shares.
Today, the last trading day of the month, there are a total of 529,262,637 shares in Vimian. 525,964,772 shares are ordinary shares with one vote per share. 938,605 shares are C shares, 1,485,532 shares are D shares, 291,237 shares are E1 2025 shares, 291,244 shares are E2 2025 shares, and 291,247 shares are E3 2025 shares, each with one-tenth of a vote per share. The total number of votes in Vimian is 526,294,558.5.
For further information, please contact:
Maria Dahllöf Tullberg
Head of IR, Communications & Sustainability [email protected]
+46 73 626 88 86
About Vimian
Vimian is a global animal health company covering four essential and rapidly evolving areas: Specialty Pharma, MedTech, Veterinary Services and Diagnostics. At Vimian, we believe that every animal deserves the best available care. We bring pioneering and entrepreneurial businesses together to make the market's most innovative offerings accessible to more animal health professionals and pet owners. Headquartered in Stockholm, Sweden, Vimian reaches over 17,000 veterinary clinics and laboratories, sells to over 80 markets, has 1,200 employees and annual revenues of approximately EUR 375 million. For more information, please visit: www.vimian.com.
This information is information that Vimian Group is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 2025-12-30 17:30 CET.